LGALS1 and lung cancer: High expression of Galectin-1 in lung cancer cell lines, as well as in human tumor tissues, alters the phenotype of monocyte-derived dendritic cells and impairs T-cell response, concomitant with increased presence of regulatory T-cells (Tregs).